KalVista Pharmaceuticals (KALV) Payables (2016 - 2024)
Historic Payables for KalVista Pharmaceuticals (KALV) over the last 10 years, with Q4 2024 value amounting to $5.7 million.
- KalVista Pharmaceuticals' Payables changed N/A to $5.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.7 million, marking a year-over-year change of. This contributed to the annual value of $9.1 million for FY2024, which is N/A changed from last year.
- Per KalVista Pharmaceuticals' latest filing, its Payables stood at $5.7 million for Q4 2024.
- In the past 5 years, KalVista Pharmaceuticals' Payables ranged from a high of $10.8 million in Q3 2024 and a low of $641000.0 during Q1 2021
- For the 4-year period, KalVista Pharmaceuticals' Payables averaged around $4.4 million, with its median value being $4.0 million (2023).
- As far as peak fluctuations go, KalVista Pharmaceuticals' Payables tumbled by 7827.85% in 2021, and later skyrocketed by 11328.06% in 2024.
- Quarter analysis of 4 years shows KalVista Pharmaceuticals' Payables stood at $2.2 million in 2020, then crashed by 70.5% to $641000.0 in 2021, then skyrocketed by 663.81% to $4.9 million in 2023, then rose by 16.95% to $5.7 million in 2024.
- Its Payables was $5.7 million in Q4 2024, compared to $5.2 million in Q4 2024 and $10.8 million in Q3 2024.